Abstract
Almost any injury to the brain may initiate disturbances in local and systemic coagulation. This statement is particularly true for subarachnoid hemorrhage, traumatic brain injuries, and cranial and spinal dural arteriovenous fistulae. The pathogenesis of coagulative disorders is highlighted from both a genetic and a structural biology perspective, along with a discussion of predictive biomarkers and clinical risk factors to guide the selection of eligible patients for primary prevention. This comprehensive review allows a better understanding of the coagulative disorders affecting patients harboring CNS diseases and accordingly offers new insights into their pharmacological and surgical treatment.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Harhangi BS et al (2008) Coagulation disorders after traumatic brain injury. Acta Neurochir 150:165–175
Linn FHH et al (1996) Incidence of subarachnoid hemorrage. Role of region, year, and rate of computed tomography: a meta-analysis. Stroke 27:625–629
Fujii Y et al (1997) Serial changes of hemostasis in aneurismal subarachnoid hemorrhage with special reference to delayed ischemic neurological deficits. J Neurosurg 86:594–602
Nina P et al (2001) A study of blood coagulation and fibrinolytic system in spontaneous subarachnoid hemorrhage: correlation with Hunt-Hess grade and outcome. Surg Neurol 55:197–203
Macdonald RL (1995) Cerebral vasospasm. Neurosurgery 5:73–97
van der Sande JJ et al (1978) Head injury and coagulation disorders. J Neurosurg 49:357–365
Juvela S et al (1990) Effect of nimodipine on platelet function in patients with subarachnoid hemorrhage. Stroke 21:1283–1288
Ohkuma H et al (1991) Role of platelet function in symptomatic cerebral vasospasm following aneurismal subarachnoid hemorrhage. Stroke 22:854–859
Peltonen S et al (1997) Hemostasis and fibrinolysis activation after subarachnoid hemorrhage. J Neurosurg 87:207–214
Ilveskero S et al (2005) D-dimer predicts outcome after aneurysmal subarachnoid hemorrhage: no effect of thromboprophylaxis on coagulation activity. J Neurosurg 57:16–24
Reiner AP et al (2001) Polymorphism of coagulation factor XIII subunit A and risk of nonfatal hemorrhagic stroke in young white women. Stroke 32:2580–2586
Vergouwen MD et al (2004) Plasminogen activator inhibitor-1 4G allele in the 4G/5G promoter polymorphism increases the occurrence of cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke 35:1280–1283
Poort SR et al (1996) A common genetic variation in the 3′-untranslated region of the prothrombin levels and an increase in venous thrombosis. Blood 88:3698–3703
Donahue BS et al (2003) Factor V Leiden protects against blood loss and transfusion after cardiac surgery. Circulation 107:10003–10008
Anwar R et al (1999) Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphism are associated with high or low factor XIII specific activity. Blood 93:897–901
Komanasin N et al (2005) A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosis. J Thromb Haemost 3:2487–2496
Kaufman HH et al (1984) Clinicopathological correlations of disseminated intravascular coagulation in patients with head injury. Neurosurgery 15:34–42
Murshid WR, Gader AG (2002) The coagulopathy in acute head injury: comparison of cerebral versus peripheral measurements of haemostatic activation markers. Br J Neurosurg 16:362–369
Olson JD et al (1989) The incidence and significance of hemostatic abnormalities in patients with head injuries. Neurosurgery 24:825–832
Piek J et al (1992) Extracranial complications of severe head injury. J Neurosurg 77:901–907
Kaufman HH et al (1980) Delayed and recurrent intracranial hematomas related to disseminated intravascular clotting and fibrinolysis in head injury. Neurosurgery 7:445–449
Stein SC et al (1993) Delayed and progressive brain injury in closed-head trauma: radiological demonstration. Neurosurgery 32:25–30; discussion 30–31
Graham DI, Adams JH (1971) Ischaemic brain damage in fatal head injuries. Lancet 1:265–266
Maeda T et al (1997) Hemodynamic depression and microthrombosis in the peripheral areas of cortical contusion in the rat: role of platelet activating factor. Acta Neurochir Suppl 70:102–105
Liu AY et al (1999) Traumatic brain injury: diffusion-weighted MR imaging findings. AJNR Am J Neuroradiol 20:1636–1641
Lee KR et al (1996) The role of the coagulation cascade in brain edema formation after intracerebral hemorrhage. Acta Neurochir 138:396–400
Hoots WK (1996) Coagulation disorders in the head-injured patient. In: Narayan RK, Wilberger JE Jr, Povlishock JT (eds) Neurotrauma. McGraw-Hill, New York, pp 673–688
Zhang ZG et al (2001) Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion. Brain Res 912:181–194
Buchanan DC et al (1989) Platelet-activating factor receptor blockade decreases early posttraumatic cerebral edema. Ann N Y Acad Sci 559:427–428
Grande PO et al (2000) Low-dose prostacyclin in treatment of severe brain trauma evaluated with microdialysis and jugular bulb oxygen measurements. Acta Anaesthesiol Scand 44:886–894
Wojcik R et al (2001) Preinjury warfarin does not impact outcome in trauma patients. J Trauma 51:1147–1151
Alberts MJ (1998) tPA in acute ischemic stroke: United States experience and issues for the future. Neurology 51:S53–S55
Tsirka SE et al (1997) Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. Proc Natl Acad Sci USA 94:9779–9781
Grabb PA (1998) Traumatic intraventricular hemorrhage treated with intraventricular recombinant-tissue plasminogen activator: technical case report. Neurosurgery 43:966–969
Aldouri M (2002) The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients. Pathophysiol Haemost Thromb 32:41–46
Vivien D, Buisson A (2000) Serine protease inhibitors: novel therapeutic targets for stroke? J Cereb Blood Flow Metab 20:755–764
Gerlach R et al (2003) Increased incidence of thrombophilic abnormalities in patients with cranial dural arteriovenous fistulae. Neurol Res 25:745–748
Herman JM et al (1995) Genesis of a dural arteriovenous malformation in a rat model. J Neurosurg 83:539–545
De Stefano V et al (1998) Epidemiology of factor V Leiden: clinical implications. Semin Thromb Hemost 24:367–379
Kraus JA et al (1998) Association of resistance to activated protein C and dural arteriovenous fistulae. J Neurol 245:731–733
Jellema K et al (2004) Spinal dural arteriovenous fistulae are not associated with prothrombotic factors. Stroke 35:2069–2071
Van Dijk JM et al (2007) Thrombophilic factors and the formation of dural arteriovenous fistulae. J Neurosurg 107:56–59
Jenkins EO et al (2010) Venous thromboembolism in malignant gliomas. J Thromb Haemost 8(2):221–227
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
Prisco, L., Ganau, M., Berlot, G. (2012). Coagulation Disorders After Central Nervous System Injury. In: Berlot, G. (eds) Hemocoagulative Problems in the Critically Ill Patient. Springer, Milano. https://doi.org/10.1007/978-88-470-2448-9_15
Download citation
DOI: https://doi.org/10.1007/978-88-470-2448-9_15
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2447-2
Online ISBN: 978-88-470-2448-9
eBook Packages: MedicineMedicine (R0)